Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonrotoclax + Pola-R-CHP in Previously Untreated Large B-Cell Lymphoma
NCT07638787Phase 2Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jun 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of sonrotoclax in diffuse large B-cell lymphoma (DLBCL), sponsored by Ruijin Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
sonrotoclax
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07638787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07638787.